- Announced positive results from the pivotal Phase 3 SIERRA trial of Iomab-B in r/r AML patients ages 55+; achieved primary endpoint of dCR with high.
Actinium Pharma (ATNM) Signs Cooperative Research and Development Agreement with National Cancer Institute streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
TUESDAY, Jan. 3, 2023 (HealthDay News) The U.S. Food and Drug Administration has approved the immunotherapy drug Tecentriq (atezolizumab) for use in patients with unresectable or metastatic alveolar soft
MONDAY, Jan. 2, 2023 (HealthDay News) Children and adults with a rare type of soft tissue cancer will now have a new treatment option that could have a big
Drug Approved to Help Young Patients Battle a Rare Cancer ashleycountyledger.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ashleycountyledger.com Daily Mail and Mail on Sunday newspapers.